Meclonazepam: Difference between revisions
CSV import |
CSV import |
||
| Line 26: | Line 26: | ||
{{stub}} | {{stub}} | ||
<gallery> | |||
File:Meclonazepam structure.svg|Meclonazepam | |||
</gallery> | |||
Latest revision as of 01:16, 20 February 2025
Meclonazepam is a drug of the benzodiazepine class. It was first synthesized by a team at Hoffmann-La Roche in the 1970s and is known for its anxiolytic, anticonvulsant, muscle relaxant, and sedative properties. It is a derivative of clonazepam and has a slow onset of action.
History[edit]
Meclonazepam was first synthesized in the 1970s by a team at Hoffmann-La Roche. It was developed as a treatment for parasitic infestations such as schistosomiasis, but it also showed potential as an anxiolytic drug.
Pharmacology[edit]
Meclonazepam is a benzodiazepine, a class of drugs known for their sedative and anxiolytic effects. It is a derivative of clonazepam, but it has a slower onset of action. This makes it less suitable for emergency use, but potentially more useful for long-term treatment of conditions such as anxiety disorders and insomnia.
Medical uses[edit]
Meclonazepam is primarily used as a treatment for parasitic infestations, including schistosomiasis. It may also be used as an anxiolytic, although this is less common.
Side effects[edit]
Like other benzodiazepines, meclonazepam can cause a range of side effects. These may include drowsiness, dizziness, confusion, and impaired coordination. Long-term use can lead to physical dependence and withdrawal symptoms if the drug is discontinued abruptly.


